Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Vaccinations

Vaccinations

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oropouche Fever: An imported case underscoring the importance of clinical and epidemiological vigilance.

Travel medicine and infectious disease·2025

Same author

A new boronate ester-based crosslinking strategy allows the design of nonswelling and long-term stable dynamic covalent hydrogels.

Biomaterials science·2023

Same author

Peacefull: A French mindfulness-based intervention for adolescents with chronic pain a feasibility study.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022

Same author

Vitamin D and calcium intakes in general pediatric populations: A French expert consensus paper.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022

Same author

Enhancement of the fatigue life of recycled PP by incorporation of recycled opaque PET collected from household milk bottle wastes.

Waste management (New York, N.Y.)·2021

Same author

Response to: Neonatal transient hypophosphatemic hypercalciuric rickets in dizygous twins.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2020

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

[Tuberculosis vaccination programs: where are we?].

C Manaouil¹, C Garnier, M Gignon

¹Consultation de médecine légale, CHU d'Amiens, place Victor-Pauchet, 80054 Amiens cedex 1, France. manaouil.cecile@chu-amiens.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie

|May 6, 2008

Summary

This summary is machine-generated.

Tuberculosis incidence declined with widespread vaccination. France now recommends BCG vaccination for at-risk children, shifting from mandatory generalized vaccination to targeted public health strategies.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Related Experiment Videos

Last Updated: Jul 5, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Area of Science:

Public Health
Epidemiology
Immunization Practices

Context:

Tuberculosis (TB) incidence significantly decreased following mandatory reporting and widespread vaccination in the mid-20th century.
Many nations have discontinued routine vaccination, opting for risk-based approaches.
France maintained obligatory generalized Bacillus Calmette-Guérin (BCG) vaccination, despite challenges with intradermal injection and side effects.

Purpose:

To evaluate the shift in French tuberculosis vaccination policy.
To analyze the rationale behind moving from generalized to risk-based BCG vaccination.
To inform public health strategies for tuberculosis control in France.

Summary:

France has transitioned from mandatory, generalized Bacillus Calmette-Guérin (BCG) vaccination to a strong recommendation for at-risk populations, particularly infants from high-incidence countries.
This policy change, announced in July 2007, aims to optimize resource allocation and minimize side effects associated with the previous intradermal method.
The initiative is coupled with a national tuberculosis control program (2007-2009) and emphasizes enhanced surveillance of tuberculosis cases.

Impact:

The policy shift aims to improve the efficiency and safety of tuberculosis prevention in France.
Targeted vaccination strategies are expected to maintain or improve population immunity against tuberculosis.
Strengthened surveillance complements vaccination efforts, contributing to the overall national tuberculosis control program.